The Moxibustion-Induced Thermal Transport Effect Between The Heart And Lung Meridians

Sponsor
Zhejiang Chinese Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT05330403
Collaborator
The Third Affiliated hospital of Zhejiang Chinese Medical University (Other)
80
1
2
32
2.5

Study Details

Study Description

Brief Summary

Although some important progresses were made in the field of the meridian research, no breakthroughs have been achieved. Besides,there are some problems in meridian researches. Particularly, previous research of meridian phenomenon involved lots of subjective elements and outcomes. Researches that use modern scientific techniques to investigate the biological characteristics of meridian phenomenon are urgently needed. Therefore, this study was designed to assess the heat transport characteristics of meridian phenomenon for the Heart and Lung meridians by using infrared thermography. Thus, the biological characteristics of meridian phenomenon could be presented objectively in a scientific methodology.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Moxibustion
N/A

Detailed Description

80 eligible subjects were finally included. Among them, 40 participants were assigned to the lung meridian intervention group, and 40 participants were assigned to the heart meridian intervention group. All 80 participants completed the trial.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
The Moxibustion-Induced Thermal Transport Effect Between The Heart And Lung Meridians With Infrared Thermography
Actual Study Start Date :
Apr 30, 2019
Actual Primary Completion Date :
Dec 30, 2021
Actual Study Completion Date :
Dec 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: the lung meridian intervention group

moxibustion intervention was performed over Site 1 (LU5) of the lung meridian

Procedure: Moxibustion
In this study, suspended moxibustion was performed by holding an ignited moxa stick at a certain distance (about 3-4 cm) over the skin surface, keeping the moxibustion Site warm without burning the skin. In the heart meridian intervention group, moxibustion was applied over Site 4 (HT3) of the heart meridian. In the lung meridian intervention group, moxibustion was performed over Site 1 (LU5) of the lung meridian.

Experimental: the heart meridian intervention group

moxibustion intervention was applied over Site 4 (HT3) of the heart meridian

Procedure: Moxibustion
In this study, suspended moxibustion was performed by holding an ignited moxa stick at a certain distance (about 3-4 cm) over the skin surface, keeping the moxibustion Site warm without burning the skin. In the heart meridian intervention group, moxibustion was applied over Site 4 (HT3) of the heart meridian. In the lung meridian intervention group, moxibustion was performed over Site 1 (LU5) of the lung meridian.

Outcome Measures

Primary Outcome Measures

  1. Temperature change of relevant sites [Baseline, Moxibustion 5 min, Moxibustion 10 min, Moxibustion 15 min, 5 minutes after stopping moxibustion]

    Infrared thermal imaging was used to record baseline temperature and the temperature change of corresponding sites along the Heart and Lung meridians.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Had recent medical examination records confirming the absence of cardiovascular, respiratory, digestive, urinary, hematological, endocrine and neurological diseases

  • 20 ≤ age ≤ 40 years, male or female

  • Had the ability to communicate with others normally

  • An understanding of the entire study protocol

  • Signed written informed consent

Exclusion Criteria:
  • Had mental illnesses, severe depression, alcohol dependence or a history of drug abuse

  • Pregnant or lactating

  • Were participating in other trials

Contacts and Locations

Locations

Site City State Country Postal Code
1 the Third affiliated hospital of Zhejiang Chinese Medical university Hanzhou Zhejiang China 310000

Sponsors and Collaborators

  • Zhejiang Chinese Medical University
  • The Third Affiliated hospital of Zhejiang Chinese Medical University

Investigators

  • Principal Investigator: Jianqiao Fang, Ph.D, Zhejiang Chinese Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jianqiao Fang, President, Zhejiang Chinese Medical University
ClinicalTrials.gov Identifier:
NCT05330403
Other Study ID Numbers:
  • 2019ZY010-MERIDIAN
First Posted:
Apr 15, 2022
Last Update Posted:
Apr 18, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jianqiao Fang, President, Zhejiang Chinese Medical University

Study Results

No Results Posted as of Apr 18, 2022